Buyout Firms Walked Blackstone Funded a Slice

$1.5 billion.

That is the most Blackstone (BX) funds will pay toward developing a Pfizer (PFE) obesity drug. The money runs through 2028. Blackstone gets milestone payments only if the monthly shot wins U.S. approval and hits sales goals. It gets no rights or stake in the drug, and Pfizer keeps control. Blackstone's fund for individual investors is taking part. The payment sizes and that fund's share were not disclosed.

Blackstone is paying for an outcome, not a company.

• Nvidia's board accepted Jensen Huang's resignation, and it took effect at once. The company gave no reason. Finance chief Colette Kress is interim chief executive and remains finance chief. Nvidia (NVDA) fell as much as 14%, then won back most of the loss to close down about 4%. It reports Tuesday.
• The 10-year Treasury yield closed at 5.1% as cash bonds reopened after the holiday. A sale of 30-year bonds drew less demand than the last one. Wednesday's PMD said that if yields climbed when cash bonds reopened, bets on income years away would cost more. Yields climbed.
• Brent settled up 3.3%, near $96, even as U.S. crude stocks grew. The gain came after President Trump said that the U.S. does not need a deal with Iran.
• Sales of existing homes fell to their slowest pace since 2010. Producer prices arrive Friday.

Two Buyout Firms Dropped Their Pursuit of Global Payments. A Report Pointed to the Deal's Size.

Clayton, Dubilier & Rice and GTCR have walked away from Global Payments, Reuters reported. The report cited two people familiar with the matter. The talks were early-stage. They did not advance "given the complexities of arranging a take-private of this scale," the report said. Efforts are on hold, and another buyer could still emerge.

Global Payments (GPN) closed down 12%, at about $88. It had jumped 13% on Oct. 30, when the interest was first reported. Most of that gain is gone. GTCR already owns about 15%, William Blair estimates.

Size is the stated problem. A buyout of a company worth about $26 billion before Thursday's drop needs a huge equity check. It also needs a debt package that lenders will hold. Reuters did not say which part proved hard, and gave no price. So the stock had carried a bid that was never formally made.

It is the second big take-private to stall this week. On Tuesday, GFL Environmental chose to stay public. Its board said the offers fell short of what the company is worth on its own.

A Bid Nobody Made Was in the Price.

For holders of stocks with buyout talk, the drop shows how much of a price can rest on talks alone. That matters because the largest deals need lenders willing to carry very big loans, and that is where size bites.

Smaller, structured deals are another matter, as Blackstone's Pfizer pact shows. A statement from Global Payments, a new approach from GTCR or a rival bidder would change this read.

SIGNAL 1: Hancock Whitney Agreed to Pay About $54 a Share for Trustmark in Stock. Its Own Shares Cut That to About $48.50.

Hancock Whitney (HWC) agreed to buy Trustmark in an all-stock deal valued at about $3.2 billion. At Wednesday's prices, each Trustmark (TRMK) share was worth about $54. That was an 18.6% premium.

Then Hancock Whitney closed down about 10%, while a regional-bank fund fell less than 1%. The swap ratio is fixed, so Trustmark's payout fell too.

The premium shrank to roughly 6.5%, and Trustmark closed just below that value. The banks project the deal lifts 2028 profit per share by about 7%. It also cuts tangible book value per share by about 7%.

WHAT RESOLVES THIS

For investors, a stock deal hands the buyer's price risk to the seller. Trustmark's premium now moves with Hancock Whitney's shares until the deal closes, expected late in next year's first quarter.

The buyer lost more market value than the premium it agreed to pay. That suggests holders are charging for more than the premium.

Both shareholder votes, and the gap between Trustmark's price and the deal value, will show how much risk the market sees.

SIGNAL 2: India May Bar Buyout Firms From Controlling More Than One Non-Bank Lender, Reuters Reported.

India's central bank is drafting limits on private equity control of non-bank lenders, Reuters reported. Under the proposals, a firm could control only one. The worry is stress at a global firm spreading to several lenders it controls. Stakes of 15% or less would face lighter scrutiny, one person said.

The news came in a week of big deals in the sector. Blackstone (BX) agreed to take about 16% of IIFL Finance. The report did not say whether existing stakes would be affected.

WHAT RESOLVES THIS

For buyout firms, the rule would steer them to minority stakes or make them pick one lender to control. That matters because these lenders have drawn both kinds of deal.

A 15% line would also shape how new deals are sized. A public draft, with its test for control and any grandfathering, would show how far the rule reaches.

• Polymarket's year-end contract on Huang's exit paid out at 100 cents. The leg dated Nov. 11 paid nothing. Nvidia (NVDA) says its board accepted the resignation that day. But the contract paid only on a public announcement, and that came Thursday.
• Bitcoin did not follow Nvidia back up. It fell to its lowest in about 12 weeks, below its 200-day average. Most of the forced selling hit bets on higher prices.
• Gold fell about 3%, below $3,900, on a day oil jumped. It fell as Treasury yields rose, though gold often serves as a hedge.

Private Market Trends Driving Public Market Moves

Whole Companies Got Harder to Buy. Slices Still Found Money.

CD&R and GTCR dropped their pursuit of Global Payments, and the stock gave back most of its buyout gain. Hancock Whitney did agree to buy a whole bank, and its own holders cut the premium within hours. Blackstone took a different route with Pfizer. It pays for trials and gets paid only if the drug succeeds. India's proposal leans the same way, with lighter rules for small stakes. The best-supported read is that money is easier to find for a defined slice of risk than for a whole company. A revived bid for Global Payments, or another large buyout signed at a premium, would weaken that read.

On the calendar...